# EMV Capital

> EMV Capital is a VC fund in London backing Medical and Health Care. See 36 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 36
- Last investment: Jul 2026
- Lead investor: 78%
- Last fund: Nov 2017
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/emvcapital/
- X (Twitter): https://twitter.com/EMVCapital
- Website: http://emvcapital.com/

EMV Capital is an award-winning VC investor specialising in early stage high-growth deep tech companies in the life science, sustainability and industrials sectors in the UK and internationally. EMV Capital develops unique investment strategies for each portfolio company, drawing on its EIS fund and extensive network of private investors, familyoffices, institutions, and corporate VCs. Delivery and successful execution of these investment strategies enables innovative portfolio companies to raise funding to drive transformational growth.EMV Capital is a wholly owned subsidiary of NetScientific plc (AIM:NSCI), a life sciences and technology commercialisation and investment group. EMV Capital has a multi-disciplinary team of specialist investors, portfolio managers, capital raisers, legal, finance, marketing and support staff. The company is focused on primary and secondary investments, through debt and/or equity.

## Contacts

5 contacts available for EMV Capital. Shizune tracks 5 team members at EMV Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/ecomachines-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 4 | 11% |
| Health Care | 4 | 11% |
| Software | 3 | 8% |
| Manufacturing | 3 | 8% |
| Energy | 2 | 6% |

41 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 8 | 22% |
| Venture - Series Unknown | 8 | 22% |
| Series A | 5 | 14% |
| Funding Round | 5 | 14% |
| Series B | 1 | 3% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 10 | 28% |
| United States | 5 | 14% |
| Israel | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Dr Ilian Iliev | Managing Director | 15 | https://shizune.co/investors/profile/ilian-iliev |
| Oliver Saban | Head of Business Development | 0 | https://shizune.co/investors/profile/oliver-saban |
| Charles Laughton | Associate Director, Corporate Finance | 0 | https://shizune.co/investors/profile/charles-laughton-d5d5 |
| Edward Hooper | Director | 2 | https://shizune.co/investors/profile/edward-hooper-83b1 |
| Gianluca Forino | Private Client Manager | 0 | https://shizune.co/investors/profile/gianluca-forino |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Dogtooth | Dogtooth is a Cambridge-based technology start-up that sells state-of-the-art intelligent robots for soft fruit picking. | $18.7M | Series B | Jul 08, 2026 |  |
| Sofant Technologies | Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems. | $8.4M | Venture - Series Unknown | Dec 23, 2025 |  |
| Wanda | Wanda Health provides remote patient monitoring solutions. They offer services that include chronic disease management, mobile applications, big data analytics, health informatics, mobile health, COVID-19 telehealth, predictive healthcare, and virtual care. | $1.7M | Venture - Series Unknown | Dec 09, 2024 |  |
| Wanda | Wanda Health provides remote patient monitoring solutions. They offer services that include chronic disease management, mobile applications, big data analytics, health informatics, mobile health, COVID-19 telehealth, predictive healthcare, and virtual care. | $63.7K | Debt Financing | Dec 09, 2024 |  |
| EpiBone | EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like living bone graft. EpiBone is strategically positioned to provide a superiorbone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year. |  | Convertible Note | Nov 08, 2024 |  |
| Sofant Technologies | Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems. | $4.3M | Venture - Series Unknown | Jun 05, 2024 |  |
| Ventive | They have developed an innovative Passive Ventilation systems with Heat Recovery for the built environment – you’ll be amazed at what we can achieve naturally without the use of costly electricity. | $1.1M |  | Nov 06, 2023 |  |
| Q-Bot | Q-BOT Ltd, a Wandsworth, London, UK-based developer of a robotics platform that can access, survey, evaluate and apply treatments in a wide range of industries and applications. The company is funded through a combination of government grants, private investment and sales revenue, and has been supported by Climate-KIC, The Technology Strategy Boardand The Department for Energy and Climate Change. | $4.4M | Venture - Series Unknown | Sep 13, 2023 |  |
| DName-iT | DName-iT is a genetic analysis tool that offers DNA-based barcode labeling technology and a software platform that can ensure reliable, cost-effective NGS specimen identification. | $634K | Seed | Jun 30, 2023 |  |
| Vortex Biosciences | Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering and informatics to deliver better tools for isolating and characterizing circulating tumor cells (CTCs). Vortex’s first product, the VTX-1 Liquid Biopsy System, automates the label free isolation and collection of viable CTCs directly fromwhole blood. | $4.1M | Venture - Series Unknown | Jun 22, 2023 |  |

10 of 36 investments shown.

## Co-investors
- [Kelvin Capital](https://shizune.co/investors/profile/kelvin-capital) — VC Fund, 10 deals together
- [NetScientific PLC](https://shizune.co/investors/profile/netscientific) — VC Fund, 7 deals together
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund, 4 deals together
- [Wealth Club](https://shizune.co/investors/profile/wealth-club) — VC Fund, 4 deals together
- [Kendall Capital Partners](https://shizune.co/investors/profile/kendall-capital-partners) — VC Fund, 2 deals together
- [Old College Capital](https://shizune.co/investors/profile/old-college-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Second Century Ventures](https://shizune.co/investors/profile/second-century-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Medical VC Funds in United Kingdom](https://shizune.co/investors/medical-vc-funds-united-kingdom)
- [Medical Investors in United Kingdom](https://shizune.co/investors/medical-investors-united-kingdom)
- [Medical Device Investors in United Kingdom](https://shizune.co/investors/medical-device-investors-united-kingdom)
- [Medical Device VC Funds in United Kingdom](https://shizune.co/investors/medical-device-vc-funds-united-kingdom)
- [Real Estate Investors in Israel](https://shizune.co/investors/real-estate-investors-israel)
- [Real Estate VC Funds in Israel](https://shizune.co/investors/real-estate-vc-funds-israel)

## FAQ

### What does EMV Capital invest in?

EMV Capital invests primarily in Medical, Health Care and Software startups, most often at Seed and Venture - Series Unknown stage. Most of the 36 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact EMV Capital?

Public channels for EMV Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at EMV Capital?

The team at EMV Capital includes Dr Ilian Iliev (Managing Director), Oliver Saban (Head of Business Development) and Charles Laughton (Associate Director, Corporate Finance). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co